findmyKOL
Clinical trialNCT06366347RecruitingPhase 2Interventional

ALPINE: Maintenance Letrozole/Abemaciclib

SponsorDana-Farber Cancer InstituteEnrollment32Endometrial CancerRecurrent Endometrial CancerTP53
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

    Meghan Shea, MD
    Recruiting
  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

    Panagiotis Konstantinopoulos, MD, PhD →
    Recruiting
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Panagiotis Konstantinopoulos, MD, PhD →
    Recruiting
  • Dana-Farber Cancer Institute at Foxborough

    Foxborough, Massachusetts, United States

    Withdrawn
  • Dana-Farber Cancer Institute at Milford

    Milford, Massachusetts, United States

    Withdrawn
  • Dana-Farber Cancer Institute at South Shore Hospital

    Weymouth, Massachusetts, United States

    Meredith Faggen, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Sept 2024
Primary completion
1 Sept 2027
Completion
1 Mar 2029
Last update posted
11 Feb 2026
Registered enrollment
32
Registry id
NCT06366347
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.